DK150088D0 - Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem - Google Patents
Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende demInfo
- Publication number
- DK150088D0 DK150088D0 DK150088A DK150088A DK150088D0 DK 150088 D0 DK150088 D0 DK 150088D0 DK 150088 A DK150088 A DK 150088A DK 150088 A DK150088 A DK 150088A DK 150088 D0 DK150088 D0 DK 150088D0
- Authority
- DK
- Denmark
- Prior art keywords
- procedures
- preparation
- pharmaceutical agents
- agents containing
- morpholine derivatives
- Prior art date
Links
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical class C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 150000002780 morpholines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Control For Baths (AREA)
- Earth Drilling (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8704047A FR2612926B1 (fr) | 1987-03-24 | 1987-03-24 | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| FR8704047 | 1987-03-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK150088D0 true DK150088D0 (da) | 1988-03-18 |
| DK150088A DK150088A (da) | 1988-09-25 |
| DK171580B1 DK171580B1 (da) | 1997-02-03 |
Family
ID=9349348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK150088A DK171580B1 (da) | 1987-03-24 | 1988-03-18 | Morpholinderivater, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende dem |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4782054A (da) |
| EP (1) | EP0286495B1 (da) |
| JP (1) | JPH0657709B2 (da) |
| AT (1) | ATE89281T1 (da) |
| AU (1) | AU600209B2 (da) |
| CA (1) | CA1313870C (da) |
| DE (1) | DE3880874T2 (da) |
| DK (1) | DK171580B1 (da) |
| ES (1) | ES2006390A6 (da) |
| FR (1) | FR2612926B1 (da) |
| GR (1) | GR1000241B (da) |
| HK (1) | HK57297A (da) |
| IE (1) | IE61882B1 (da) |
| NZ (1) | NZ223984A (da) |
| OA (1) | OA08822A (da) |
| PT (1) | PT87061B (da) |
| ZA (1) | ZA882107B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653999A1 (fr) * | 1989-11-06 | 1991-05-10 | Adir | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
| US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| AP2006003771A0 (en) | 2004-04-30 | 2006-10-31 | Warner Lambert Co | Substituted morpholine compounds for the treatmentof central nervous system disorders |
| GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1138405A (en) * | 1966-12-28 | 1969-01-01 | Ici Ltd | Morpholine derivatives |
| BE758766A (fr) * | 1969-11-17 | 1971-05-10 | Ici Ltd | Nouveaux derives de la morpholine et de la |
-
1987
- 1987-03-24 FR FR8704047A patent/FR2612926B1/fr not_active Expired
-
1988
- 1988-03-04 US US07/164,103 patent/US4782054A/en not_active Expired - Lifetime
- 1988-03-09 CA CA000561016A patent/CA1313870C/fr not_active Expired - Fee Related
- 1988-03-18 DK DK150088A patent/DK171580B1/da not_active IP Right Cessation
- 1988-03-23 GR GR880100179A patent/GR1000241B/el not_active IP Right Cessation
- 1988-03-23 PT PT87061A patent/PT87061B/pt not_active IP Right Cessation
- 1988-03-23 JP JP63069198A patent/JPH0657709B2/ja not_active Expired - Lifetime
- 1988-03-23 EP EP88400693A patent/EP0286495B1/fr not_active Expired - Lifetime
- 1988-03-23 NZ NZ223984A patent/NZ223984A/xx unknown
- 1988-03-23 DE DE88400693T patent/DE3880874T2/de not_active Expired - Fee Related
- 1988-03-23 IE IE85188A patent/IE61882B1/en not_active IP Right Cessation
- 1988-03-23 AT AT88400693T patent/ATE89281T1/de active
- 1988-03-23 AU AU13520/88A patent/AU600209B2/en not_active Ceased
- 1988-03-24 ZA ZA882107A patent/ZA882107B/xx unknown
- 1988-03-24 OA OA59308A patent/OA08822A/xx unknown
- 1988-03-24 ES ES8800903A patent/ES2006390A6/es not_active Expired
-
1997
- 1997-05-01 HK HK57297A patent/HK57297A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2006390A6 (es) | 1989-04-16 |
| JPH0657709B2 (ja) | 1994-08-03 |
| OA08822A (fr) | 1989-03-31 |
| AU1352088A (en) | 1988-09-22 |
| ZA882107B (en) | 1989-06-28 |
| GR880100179A (en) | 1989-01-31 |
| PT87061B (pt) | 1992-07-31 |
| JPS63255279A (ja) | 1988-10-21 |
| US4782054A (en) | 1988-11-01 |
| EP0286495B1 (fr) | 1993-05-12 |
| FR2612926B1 (fr) | 1989-06-09 |
| DE3880874D1 (de) | 1993-06-17 |
| GR1000241B (el) | 1992-05-12 |
| ATE89281T1 (de) | 1993-05-15 |
| DK150088A (da) | 1988-09-25 |
| IE61882B1 (en) | 1994-11-30 |
| PT87061A (pt) | 1988-04-01 |
| AU600209B2 (en) | 1990-08-02 |
| DE3880874T2 (de) | 1993-12-23 |
| DK171580B1 (da) | 1997-02-03 |
| HK57297A (en) | 1997-05-09 |
| IE880851L (en) | 1988-09-24 |
| FR2612926A1 (fr) | 1988-09-30 |
| NZ223984A (en) | 1990-05-28 |
| CA1313870C (fr) | 1993-02-23 |
| EP0286495A1 (fr) | 1988-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO162467C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (1,5)-pyridiner og deres dihydro- og tetrahydroderivater. | |
| NO992524L (no) | Konsenserte bicykliske pyrimidin-derivater | |
| DK150088A (da) | Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| SE7703083L (sv) | Forfarande for framstellning av piperidinderivat | |
| AU534470B2 (en) | Paromomycin derivatives | |
| DK119188A (da) | Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne | |
| NO932722L (no) | Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon | |
| DK279988D0 (da) | Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| PT85866A (en) | Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives | |
| DK0427605T3 (da) | Hidtil ukendte morfolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
| DK222588D0 (da) | 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler | |
| NO865347L (no) | Fremgangsmaate for fremstilling av pyrimido (5,4-b)(1,4)oxazinderivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |